- Investing Ideas
- Japanese Pharmaceuticals & Biotech Top Stock Picks from Analysts
Japanese Pharmaceuticals & Biotech Top Stock Picks from Analysts
Results
12
Companies which are more than 50% undervalued based on analyst price target.
12 companies
Sumitomo Pharma
Market Cap: JP¥583.4b
Manufactures, purchases, and sells pharmaceutical products for medical treatment in Japan, North America, and Asia.
4506
JP¥1,300.50
7D
3.1%
1Y
14.4%
GNI Group
Market Cap: JP¥169.4b
Engages in the research, development, manufacturing, and sale of pharmaceuticals and biomaterials in Japan, China, and the United States.
2160
JP¥2,575.00
7D
5.5%
1Y
-8.2%
PeptiDream
Market Cap: JP¥122.8b
A biopharmaceutical company, engages in the discovery and development of constrained peptides, small molecules, and peptide-drug conjugate therapeutics.
4587
JP¥955.80
7D
-2.0%
1Y
-44.2%
Nxera Pharma
Market Cap: JP¥83.4b
Operates as a biopharmaceutical company, engages in drug discovery and development in Japan, the United States, Germany, Switzerland, Bermuda, the United Kingdom, and internationally.
4565
JP¥901.00
7D
-0.9%
1Y
2.9%
SanBio
Market Cap: JP¥75.4b
Engages in the development, production, and sale of regenerative cell medicines for the central nervous system in Japan and the United States.
4592
JP¥966.00
7D
-6.7%
1Y
-56.6%
Fuji Pharma
Market Cap: JP¥48.8b
Engages in the research and development, manufacture, and marketing of pharmaceutical products in Japan and internationally.
4554
JP¥1,869.00
7D
-2.7%
1Y
31.7%
Heartseed
Market Cap: JP¥39.3b
Develops and commercializes iPS cell-derived cardiomyocyte replacement therapy for heart failure.
219A
JP¥1,717.00
7D
14.8%
1Y
-53.5%
Healios K.K
Market Cap: JP¥32.8b
Engages in the research, development, manufacturing, and sale of cell therapy and regenerative medicine products in Japan, Europe, and the United States.
4593
JP¥243.00
7D
-5.1%
1Y
-63.6%
StemRIM
Market Cap: JP¥18.7b
A biotechnology company, researches and develops regeneration-inducing medicine in Japan and internationally.
4599
JP¥299.00
7D
1.7%
1Y
-3.2%
Kidswell Bio
Market Cap: JP¥7.1b
Develops pharmaceutical products for the treatment of pediatric, pediatric, intractable, and Asia-endemic diseases in Japan.
4584
JP¥143.00
7D
-2.1%
1Y
-48.2%
Noile-Immune Biotech
Market Cap: JP¥6.2b
Researches and develops CAR-T cells for novel cancer immunotherapies.
4893
JP¥142.00
7D
2.2%
1Y
-17.9%
TMS
Market Cap: JP¥4.4b
Engages in the research and development, manufacture, and sale of drug products, quasi-drugs, drug substances, medical devices, and medical commodities.
4891
JP¥97.00
7D
-3.0%
1Y
-41.6%